Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels-Reference-Cited by-同舟云学术

Chemotherapeutic Drugs Inhibit Ribosome Biogenesis at Various Levels

Published:2010-04 Issue:16 Volume:285 Page:12416-12425
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Burger Kaspar,Mühl Bastian,Harasim Thomas,Rohrmoser Michaela,Malamoussi Anastassia,Orban Mathias,Kellner Markus,Gruber-Eber Anita,Kremmer Elisabeth,Hölzel Michael,Eick Dirk

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference37 articles.

1. Disruption of p53 in human cancer cells alters the responses to therapeutic agents

2. 5-Fluorouracil Enhances Exosome-Dependent Accumulation of Polyadenylated rRNAs

3. Incorporation of 5-fluorouracil into U2 and U6 snRNA inhibits mRNA precursor splicing.

4. 5-Fluorouracil: mechanisms of action and clinical strategies

Cited by 365 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced transcriptome analysis in zebrafish uncovers disruptors of spliceosome and ribosome biosynthesis;Science of The Total Environment;2024-11

2. Targeting ribosome biogenesis as a novel therapeutic approach to overcome EMT-related chemoresistance in breast cancer;eLife;2024-09-11

3. Multi-omic and functional screening reveal targetable vulnerabilities inTP53mutated multiple myeloma;2024-08-23

4. Targeting Ribosome Biogenesis as a Novel Therapeutic Approach to Overcome EMT-related Chemoresistance in Breast Cancer;2024-08-20

5. Topological stress triggers persistent DNA lesions in ribosomal DNA with ensuing formation of PML-nucleolar compartment;2024-08-19